Table 1.
Evaluation of liver and body weight, and liver to body weight ratio, serum chemistry and levels of TGF-β1 in serum and cholangiocyte supernatant.
Parameters | C57 | FVB | C57/FVB | SR−/− | Mdr2−/− | SR−/−/Mdr2−/− |
---|---|---|---|---|---|---|
| ||||||
Liver weight (gm) | 1.7±0.3 | 1.6±0.1 | 1.6±0.1 | 1.6±0.4 | 2.6±0.1* | 2.2±0.1 |
n=34 | n=13 | n=12 | n=15 | n=15 | n=11 | |
| ||||||
Body weight (gm) | 26.0±0.5 | 30.0±0.5 | 31.1±1.4 | 32.0 ± 1.5 | 30.6±0.4 | 30.6±1.1 |
n=34 | n=13 | n=12 | n=15 | n=15 | n=11 | |
| ||||||
Liver to body weight ratio (%) | 6.4±0.2 | 5.4±0.1 | 5.2±0.3 | 5.7±0.2 | 8.5±0.3* | 7.2±0.1# |
n=34 | n=13 | n=12 | n=15 | n=15 | n=11 | |
| ||||||
SGPT (Units/L) | 326.3±32.6 | 131.3±16.6 | 124.3±11.9 | 321.5±68.4 | 1153.5±55.6* | 794.5±21.9# |
n=4 | n=4 | n=4 | n=4 | n=4 | n=4 | |
| ||||||
SGOT (Units/L) | 485.0±53.5 | 431.3±25.9 | 570±89.8 | 427.5±174.3 | 1710.3±216.8* | 893.8±102.8# |
n=4 | n=4 | n=4 | n=4 | n=4 | n=4 | |
| ||||||
ALP (Units/L) | <45±5.0 | <50±0.0 | <56.5±6.5 | <47.25±2.8 | 342.5±27.2* | 237.0±17.5# |
n=4 | n=4 | n=4 | n=4 | n=4 | n=4 | |
| ||||||
TGF-β1 levels in serum (pg/ml) | 276.9±36.3 | 78.7±4.7 | 118.5±10.2 | 69.4±0.8 | 7970.7±304.8* | 1617.5±132.3# |
n=4 | n=4 | n=4 | n=4 | n=4 | n=4 | |
| ||||||
TGF-β1 levels in cholangiocyte supernatant (ng/ml) | 4.0±0.5 | 0.5±0.3 | 1.3±0.5 | 24.7±1.2 | 764.5±30.0* | 216.9±10.6# |
n=4 | n=4 | n=4 | n=4 | n=4 | n=4 |
P<0.05 vs. FVB mice;
P<0.05 vs. Mdr2−/− mice.